Literature DB >> 14586893

Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury.

Hugo R Rosen1.   

Abstract

1. The development of hepatitis C virus (HCV) quasispecies has a number of biological consequences, including the development of escape mutants to humoral or cellular immunity, the generation of "defective" viral particles, variable cell tropism, and the development of drug resistance. 2. Accumulating evidence shows that HCV affects the early innate immune response mediated by natural killer and dendritic cells. 3. Recent data suggest that clearance of HCV bestows antibody to HCV immunity that affords partial protection against persistent infection. However, after spontaneous recovery from HCV infection, titers of HCV-specific antibodies decline and disappear in a subset of patients, whereas viral-specific CD4(+) and CD8(+) T-cell responses persist for decades. 4. HCV-specific CD8(+) T-cell responses are phenotypically and functionally diverse and may be associated with either viral eradication or chronic hepatic immunopathologic states. 5. Novel HCV genome-wide screening approaches have shown that the breadth of the immune response is considerably greater than was initially appreciated using more conventional assays, but why the majority of patients remain chronically infected despite the presence of viral-specific immune responses remains undefined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586893     DOI: 10.1053/jlts.2003.50253

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  12 in total

Review 1.  Natural course, therapeutic options and economic evaluation of therapies for chronic hepatitis B.

Authors:  Steven-Huy B Han
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities.

Authors:  Lisa Maher; Bethany White; Margaret Hellard; Annie Madden; Maria Prins; Thomas Kerr; Kimberly Page
Journal:  Vaccine       Date:  2010-09-09       Impact factor: 3.641

3.  T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus.

Authors:  R Aggarwal; R Shukla; S Jameel; S Agrawal; P Puri; V K Gupta; A P Patil; S Naik
Journal:  J Viral Hepat       Date:  2007-04       Impact factor: 3.728

4.  Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver.

Authors:  James G Cripps; Jing Wang; Ann Maria; Ian Blumenthal; James D Gorham
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

5.  Reduction of virus burden-induced splenectomy in patients with liver cirrhosis related to hepatitis C virus infection.

Authors:  Tetsuro Sekiguchi; Takeaki Nagamine; Hitoshi Takagi; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

6.  End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas.

Authors:  Richard T Robinson; Jing Wang; James G Cripps; Michael W Milks; Kathryn A English; Todd A Pearson; James D Gorham
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

7.  Association between inherited monogenic liver disorders and chronic hepatitis C.

Authors:  Linda Piekuse; Madara Kreile; Agnese Zarina; Zane Steinberga; Valentina Sondore; Jazeps Keiss; Baiba Lace; Astrida Krumina
Journal:  World J Hepatol       Date:  2014-02-27

8.  Regulation of immune response and inflammatory reactions against viral infection by VCAM-1.

Authors:  Rong Ou; Menghua Zhang; Lei Huang; Richard A Flavell; Pandelakis A Koni; Demetrius Moskophidis
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

Review 9.  Innate immune responses in hepatitis C virus infection.

Authors:  Kui Li; Stanley M Lemon
Journal:  Semin Immunopathol       Date:  2012-08-07       Impact factor: 9.623

10.  The association of human immunodeficiency virus infection with spontaneously resolved hepatitis C virus infection and level of viremia among injection drug users.

Authors:  Karen H Seal; Alex Monto; Lorna Dove; Hui Shen; Eric Vittinghoff; Daniel Tracy; Erica Miller; Eva Lau; Teresa L Wright
Journal:  Dig Dis Sci       Date:  2007-04-19       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.